Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Innovent Biologics, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 29.43% vs 2.97% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 55.18% vs 22.94% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,857.70",
          "val2": "5,298.50",
          "chgp": "29.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,114.60",
          "val2": "-2,735.90",
          "chgp": "59.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "109.00",
          "val2": "118.30",
          "chgp": "-7.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "23.50",
          "val2": "22.00",
          "chgp": "6.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,135.80",
          "val2": "-2,534.20",
          "chgp": "55.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-162.50%",
          "val2": "-586.40%",
          "chgp": "42.39%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

6,857.70

5,298.50

29.43%

Operating Profit (PBDIT) excl Other Income

-1,114.60

-2,735.90

59.26%

Interest

109.00

118.30

-7.86%

Exceptional Items

23.50

22.00

6.82%

Consolidate Net Profit

-1,135.80

-2,534.20

55.18%

Operating Profit Margin (Excl OI)

-162.50%

-586.40%

42.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 29.43% vs 2.97% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 55.18% vs 22.94% in Dec 2022

All Annual Results